Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1979 1
1981 1
1982 7
1983 6
1984 4
1985 1
1986 2
1987 1
1988 1
1990 2
1993 1
1995 1
1996 1
1998 3
1999 1
2000 2
2001 1
2002 1
2003 1
2004 2
2005 1
2006 2
2008 1
2009 1
2013 1
2015 1
2017 1
2020 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: 33564-31-7
Page 1
Diflorasone.
[No authors listed] [No authors listed] 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Jan 18. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000883 Free Books & Documents. Review.
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids may cause systemic effects in the mother, it is unlikely that short-term application of topical corticosteroids would pose a risk to the breas …
Topical diflorasone has not been studied during breastfeeding. Since only extensive application of the most potent corticosteroids ma …
Drugs for atopic dermatitis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2020 Jun 15;62(1600):89-96. Med Lett Drugs Ther. 2020. PMID: 32555122 No abstract available.
Structures from powders: diflorasone diacetate.
Maccaroni E, Giovenzana GB, Palmisano G, Botta D, Volante P, Masciocchi N. Maccaroni E, et al. Steroids. 2009 Jan;74(1):102-11. doi: 10.1016/j.steroids.2008.09.014. Epub 2008 Oct 18. Steroids. 2009. PMID: 19013475
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment of skin disorders, can be prepared as anhydrous form, DD1 (as deposited in the US pharmacopoeia), or as a monohydrated phase, DDW. ...
Diflorasone diacetate, a steroid anti-inflammatory drug (marketed as Diacort or Florone by Pfizer) and used in the treatment o …
A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy.
Kaidbey K, Kopper SC, Sefton J, Gibson JR. Kaidbey K, et al. Int J Dermatol. 2001 Jul;40(7):468-71. doi: 10.1046/j.1365-4362.2001.01234.x. Int J Dermatol. 2001. PMID: 11679006 Clinical Trial.
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to each of six sites on their forearms: no treatment, tazarotene vehicle, tazarotene vehicle + tazarotene gel 0.1%, diflorasone diac …
METHODS: Each of 24 healthy volunteers received the following six treatments (applied 6 days per week for 4 weeks), which were randomized to …
Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
Johansson EA, Stiger TR. Johansson EA, et al. Curr Med Res Opin. 1984;9(4):259-64. doi: 10.1185/03007998409109589. Curr Med Res Opin. 1984. PMID: 6510015 Clinical Trial.
The efficacy of once a day applications of 0.05% diflorasone diacetate ointment and twice a day applications of 0.1% betamethasone valerate ointment was compared in 70 patients with eczematous dermatitis. ...At Week 3, this difference in the improvement of pruritus …
The efficacy of once a day applications of 0.05% diflorasone diacetate ointment and twice a day applications of 0.1% betametha …
[Topical treatment of glucocorticoid-sensitive dermatoses with diflorasone diacetate].
Rozman TA. Rozman TA. Z Hautkr. 1986 Mar 1;61(5):294, 297-304. Z Hautkr. 1986. PMID: 3962411 German.
Treatment with diflorasone diacetate ointment and cream (0.05%) was strikingly successful in a multicenter clinical trial involving 4,651 patients in total suffering from various corticosteroid-sensitive dermatoses. ...Clinical and experimental results confirm that …
Treatment with diflorasone diacetate ointment and cream (0.05%) was strikingly successful in a multicenter clinical trial invo …
A medication error.
Servodidio CA, Abramson DH. Servodidio CA, et al. Insight. 1996 Jun;21(2):49. doi: 10.1016/s1060-135x(96)90058-5. Insight. 1996. PMID: 8954365 Free article.
A patient had inadvertently mistaken her son's diflorasone diacetate ointment for gentamicin sulfate ophthalmic ointment and applied it to her eye in error. ...
A patient had inadvertently mistaken her son's diflorasone diacetate ointment for gentamicin sulfate ophthalmic ointment and a …
Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L. Bluefarb SM, et al. J Int Med Res. 1976;4(6):454-61. doi: 10.1177/030006057600400613. J Int Med Res. 1976. PMID: 800385 Clinical Trial.
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fluocinonide, beta-methasone 17-valerate and fluocinolone acetonide) when the compounds were dissolved in 95% alcohol and applied in vasoconst …
Diflorasone diacetate, a new topical corticosteroid, was generally more potent than three high potency reference standards (fl …
Comparison of diflorasone diacetate and betamethasone dipropionate ointment in the treatment of psoriasis.
Leibsohn E. Leibsohn E. J Int Med Res. 1982;10(1):22-7. doi: 10.1177/030006058201000104. J Int Med Res. 1982. PMID: 7073809 Clinical Trial.
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic, were treated with either diflorasone diacetate ointment 0.05% or betamethasone dipropionate ointment 0.05% twice a day for 3 …
In this double-blind study, 100 patients with mild, moderate, or severe thick lesion psoriasis, characterized as acute, subacute, or chronic …
Comparative efficacy of once-daily flurandrenolide tape versus twice-daily diflorasone diacetate ointment in the treatment of psoriasis.
Krueger GG, O'Reilly MA, Weidner M, Dromgoole SH, Killey FP. Krueger GG, et al. J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):186-90. doi: 10.1016/s0190-9622(98)70238-5. J Am Acad Dermatol. 1998. PMID: 9486672 Clinical Trial.
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diacetate ointment in plaque psoriasis. METHODS: Thirty patients participated in an investigator-blinded, randomized, bilateral paired-compa …
OBJECTIVE: Our purpose was to determine the relative efficacy of flurandrenolide (4 microg/cm2) tape versus 0.05% diflorasone diac …
51 results